Rnd3 regulates lung cancer cell proliferation through Notch signaling

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Tang, Yongjun ^a   Hu, Chengping ^a   Yang, Huaping ^a   Cao, Liming ^a   Li, Yuanyuan ^a   Deng, Pengbo ^a   Huang, Li ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NOTCH INTRACELLULAR DOMAIN PROTEIN; NOTCH RECEPTOR; PROTEASOME; PROTEIN RND3; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; RND3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; GENE EXPRESSION; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; RECEPTORS, NOTCH; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84910671550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111897     Document Type: Article

References (36)

1. Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, et al. (2009) gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res 69:573-582.
2. Zheng Q, Qin H, Zhang H, Li J, Hou L, et al. (2007) Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. Oncology reports 17:847-852.
3. Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, et al. (2007) Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res 67:7954-7959.
4. Westhoff B, Colaluca IN, D'Ario G, Donzelli M, Tosoni D, et al. (2009) Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A 106:22293-22298.
5. Riento K, Guasch RM, Garg R, Jin B, Ridley AJ (2003) RhoE binds to ROCK I and inhibits downstream signaling. Mol Cell Biol 23:4219-4229.
6. Katoh H, Harada A, Mori K, Negishi M (2002) Socius is a novel Rnd GTPaseinteracting protein involved in disassembly of actin stress fibers. Molecular and cellular biology 22:2952-2964.
7. Lin X, Liu B, Yang X, Yue X, Diao L, et al. (2013) Genetic deletion of Rnd3 results in aqueductal stenosis leading to hydrocephalus through up-regulation of Notch signaling. Proceedings of the National Academy of Sciences of the United States of America.
8. Xia H, Li M, Chen L, Leng W, Yuan D, et al. (2013) Suppression of RND3 activity by AES downregulation promotes cancer cell proliferation and invasion. Int J Mol Med 31:1081-1086.
9. Ongusaha PP, Kim HG, Boswell SA, Ridley AJ, der CJ, et al. (2006) RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress. Curr Biol 16:2466-2472.
10. Ma W, Wong CC, Tung EK, Wong CM, Ng IO (2013) RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway. Hepatology 57:152-161.
11. Zhao H, Yang J, Fan T, Li S, Ren X (2012) RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3 K/Akt signaling pathway. Tumour Biol 33:1363-1374.
12. Belgiovine C, Frapolli R, Bonezzi K, Chiodi I, Favero F, et al. (2010) Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells. PLoS One 5:e14154.
13. Villalonga P, Guasch RM, Riento K, Ridley AJ (2004) RhoE inhibits cell cycle progression and Ras-induced transformation. Mol Cell Biol 24:7829-7840.
14. Pinner S, Sahai E (2008) PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nature cell biology 10:127-137.
15. Satoh S, Utsunomiya T, Tsurui K, Kobayashi T, Ikegaki I, et al. (2001) Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life Sci 69:1441-1453.
16. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, et al. (2002) Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105:1545-1547.
17. Grimwood S, Hogg J, Jay MT, Lad AM, Lee V, et al. (2005) Determination of guinea-pig cortical gamma-secretase activity ex vivo following the systemic administration of a gamma-secretase inhibitor. Neuropharmacology 48:1002-1011.
18. Liu J, Mao Z, Huang J, Xie S, Liu T (2014) Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Biochem Biophys Res Commun 444:670-675.
19. Marcelo KL, Sills TM, Coskun S, Vasavada H, Sanglikar S, et al. (2013) Hemogenic endothelial cell specification requires c-Kit, Notch signaling, and p27-mediated cell-cycle control. Dev Cell 27:504-515.
20. Dai Y, Wilson G, Huang B, Peng M, Teng G, et al. (2014) Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell death & disease 5:e1170.
21. Lin X, Liu B, Yang X, Yue X, Diao L, et al. (2013) Genetic deletion of Rnd3 results in aqueductal stenosis leading to hydrocephalus through up-regulation of Notch signaling. Proc Natl Acad Sci U S A 110:8236-8241.
22. McGill MA, McGlade CJ (2003) Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem 278:23196-23203.
23. Grise F, Sena S, Bidaud-Meynard A, Baud J, Hiriart JB, et al. (2012) Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology 55:1766-1775.
24. Gress TM, Muller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, et al. (1996) A pancreatic cancer-specific expression profile. Oncogene 13:1819-1830.
25. Akashi H, Han HJ, Iizaka M, Nakamura Y (2000) Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int J Cancer 88:873-880.
26. van Groningen JJ, Cornelissen IM, van Muijen GN, Bloemers HP, Swart GW (1996) Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene. Biochem Biophys Res Commun 225:808-816.
27. Zhang C, Zhou F, Li N, Shi S, Feng X, et al. (2007) Overexpression of RhoE has a prognostic value in non-small cell lung cancer. Annals of surgical oncology 14:2628-2635.
28. Cuiyan Z, Jie H, Fang Z, Kezhi Z, Junting W, et al. (2007) Overexpression of RhoE in Non-small Cell Lung Cancer (NSCLC) is associated with smoking and correlates with DNA copy number changes. Cancer Biol Ther 6:335-342.
29. Bektic J, Pfeil K, Berger AP, Ramoner R, Pelzer A, et al. (2005) Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis. Prostate 64:332-340.
30. Pacary E, Heng J, Azzarelli R, Riou P, Castro D, et al. (2011) Proneural transcription factors regulate different steps of cortical neuron migration through Rnd-mediated inhibition of RhoA signaling. Neuron 69:1069-1084.
31. Li J, Anton ES (2011) Rnd-ing up RhoA activity to link neurogenesis with steps in neuronal migration. Dev Cell 20:409-410.
32. Katiyar P, Aplin AE (2011) FOXD3 Regulates Migration Properties and Rnd3 Expression in Melanoma Cells. Molecular cancer research: MCR 9:545-552.
33. Jiang X, Zhou JH, Deng ZH, Qu XH, Jiang HY, et al. (2007) [Expression and significance of Notch1, Jagged1 and VEGF in human non-small cell lung cancer]. Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences 32:1031-1036.
34. Zhu Z, Todorova K, Lee KK, Wang J, Kwon E, et al. (2014) Small GTPase RhoE/Rnd3 Is a Critical Regulator of Notch1 Signaling. Cancer Res 74:2082-2093.
35. Zhou J, Yang J, Li K, Mo P, Feng B, et al. (2013) RhoE is associated with relapse and prognosis of patients with colorectal cancer. Annals of surgical oncology 20:175-182.
36. Luo H, Dong Z, Zou J, Zeng Q, Wu D, et al. (2012) Down-regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma. J Surg Oncol 105:699-704.